logo-loader

Allergy Therapeutics celebrating 20 years of growth and innovation

Published: 19:38 06 Mar 2019 AEDT

Allergy Therapeutics PLC's (LON:AGY) CEO Manuel Llobet and chief financial officer Nick Wykeman discuss with Proactive London's Andrew Scott the group's results for the six months to December 2018.

The company saw turnover rise 10.6% to £46.7mln in the period, up from £42.2mln a year earlier.

2019 is Allergy's 20th anniversary since they spun out of GlaxoSmithKline.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

6 hours, 46 minutes ago